J C Weeks

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Relationship between cancer patients' predictions of prognosis and their treatment preferences
    J C Weeks
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115 6084, USA
    JAMA 279:1709-14. 1998
  2. ncbi request reprint Use of breast-conserving surgery for treatment of stage I and stage II breast cancer
    E Guadagnoli
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    J Clin Oncol 16:101-6. 1998
  3. ncbi request reprint Age-related patterns of care: evidence against ageism in the treatment of early-stage breast cancer
    E Guadagnoli
    Health Care Policy, Department of Medicine, Harvard Medical School, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 15:2338-44. 1997
  4. ncbi request reprint Predicting costs of stem-cell transplantation
    S J Lee
    Department of Adult Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    J Clin Oncol 18:64-71. 2000
  5. ncbi request reprint Who gets chemotherapy for metastatic lung cancer?
    C C Earle
    Center for Outcomes and Policy Research, Department of Adult Oncology Dana Farber Cancer Institute, Boston, MA 02115, USA
    Chest 117:1239-46. 2000
  6. ncbi request reprint Improving discussion of surgical treatment options for patients with breast cancer: local medical opinion leaders versus audit and performance feedback
    E Guadagnoli
    Departmnent of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Breast Cancer Res Treat 61:171-5. 2000
  7. ncbi request reprint Quality of informed consent in cancer clinical trials: a cross-sectional survey
    S Joffe
    Department of Paediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
    Lancet 358:1772-7. 2001
  8. ncbi request reprint Quality of informed consent: a new measure of understanding among research subjects
    S Joffe
    Department of Pediatrics, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Children's Hospital, Boston, USA
    J Natl Cancer Inst 93:139-47. 2001
  9. ncbi request reprint Recovery after stem-cell transplantation for hematologic diseases
    S J Lee
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 19:242-52. 2001
  10. ncbi request reprint Discrepancies between patient and physician estimates for the success of stem cell transplantation
    S J Lee
    Center for Outcomes and Policy Research, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    JAMA 285:1034-8. 2001

Detail Information

Publications17

  1. ncbi request reprint Relationship between cancer patients' predictions of prognosis and their treatment preferences
    J C Weeks
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115 6084, USA
    JAMA 279:1709-14. 1998
    ....
  2. ncbi request reprint Use of breast-conserving surgery for treatment of stage I and stage II breast cancer
    E Guadagnoli
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    J Clin Oncol 16:101-6. 1998
    ..To assess the use of breast-conserving surgery in two states reported to differ with respect to surgical treatment of breast cancer...
  3. ncbi request reprint Age-related patterns of care: evidence against ageism in the treatment of early-stage breast cancer
    E Guadagnoli
    Health Care Policy, Department of Medicine, Harvard Medical School, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 15:2338-44. 1997
    ..To assess whether the use of adjuvant systemic therapy in postmenopausal women with early-stage breast cancer is influenced by patient age...
  4. ncbi request reprint Predicting costs of stem-cell transplantation
    S J Lee
    Department of Adult Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    J Clin Oncol 18:64-71. 2000
    ..We sought (1) to determine whether obtaining baseline information enabled identification of patients whose treatments would be the most costly and (2) to estimate inpatient costs for managing specific transplantation complications...
  5. ncbi request reprint Who gets chemotherapy for metastatic lung cancer?
    C C Earle
    Center for Outcomes and Policy Research, Department of Adult Oncology Dana Farber Cancer Institute, Boston, MA 02115, USA
    Chest 117:1239-46. 2000
    ..To determine the prevalence and factors associated with chemotherapy use in elderly patients presenting with advanced lung cancer...
  6. ncbi request reprint Improving discussion of surgical treatment options for patients with breast cancer: local medical opinion leaders versus audit and performance feedback
    E Guadagnoli
    Departmnent of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Breast Cancer Res Treat 61:171-5. 2000
    ..001) from 33% to 17%, but a similar decrease was observed among control hospitals. Using medical opinion leaders to intervene in hospitals appeared as effective as performance feedback...
  7. ncbi request reprint Quality of informed consent in cancer clinical trials: a cross-sectional survey
    S Joffe
    Department of Paediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
    Lancet 358:1772-7. 2001
    ..Efforts to educate providers and participants about the underlying goals of clinical trials are needed...
  8. ncbi request reprint Quality of informed consent: a new measure of understanding among research subjects
    S Joffe
    Department of Pediatrics, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Children's Hospital, Boston, USA
    J Natl Cancer Inst 93:139-47. 2001
    ..2 minutes to complete. CONCLUSIONS: The QuIC is a brief, reliable, and valid questionnaire that holds promise as a standardized way to assess the outcome of the informed consent process in cancer clinical trials...
  9. ncbi request reprint Recovery after stem-cell transplantation for hematologic diseases
    S J Lee
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 19:242-52. 2001
    ....
  10. ncbi request reprint Discrepancies between patient and physician estimates for the success of stem cell transplantation
    S J Lee
    Center for Outcomes and Policy Research, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    JAMA 285:1034-8. 2001
    ..Stem cell transplantation is associated with considerable morbidity and mortality. The extent to which patients and their physicians correctly estimate these risks is unknown...
  11. ncbi request reprint Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care
    J Wolfe
    Center for Outcomes and Policy Research and Department of Pediatric Oncology, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    JAMA 284:2469-75. 2000
    ..However, a more accurate understanding of prognosis could alter treatment goals and expectations and lead to more effective care...
  12. ncbi request reprint Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer
    J A Hayman
    Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    J Clin Oncol 15:1252-60. 1997
    ..To assess patients' preferences regarding the trade-off between risks and benefits of radiation therapy after conservative surgery for early-stage breast cancer...
  13. ncbi request reprint Outcomes research in oncology: history, conceptual framework, and trends in the literature
    S J Lee
    Center for Outcomes and Policy Research, Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Natl Cancer Inst 92:195-204. 2000
    ..We suggest that as different branches of investigation develop their own literature and methodology-in effect, outgrowing the generic label of outcomes research-they become identified by separate, more precise terms...
  14. ncbi request reprint Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis
    C C Earle
    Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 19:1064-70. 2001
    ..To compare the effectiveness of chemotherapy given to elderly patients in routine practice for stage IV non-small-cell lung cancer (NSCLC) with the efficacy observed in randomized trials...
  15. ncbi request reprint Discussion of treatment options for early-stage breast cancer: effect of provider specialty on type of surgery and satisfaction
    N L Keating
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Med Care 39:681-91. 2001
    ..To describe the physicians with whom breast cancer patients discuss treatment options and assess whether discussing surgical options with a medical oncologist is associated with type of surgery and satisfaction...
  16. ncbi request reprint Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study
    J A Talcott
    Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA, USA
    J Clin Oncol 16:275-83. 1998
    ..To assess complications of therapy for early (nonmetastatic) prostate cancer...
  17. pmc What do patients value in their hospital care? An empirical perspective on autonomy centred bioethics
    S Joffe
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Med Ethics 29:103-8. 2003
    ..We sought to examine the relative influence of involvement in decisions, confidence and trust in providers, and treatment with respect and dignity on patients' evaluations of their hospital care...